State of Illinois Illinois Department of Public Health Ryan White Part B ADAP Medication Assistance Program (MAP) Application for Pre Approval of Hepatitis C Medication Assistance The following medications are n o w avai

First Page		Document Content
Date: 2016-05-03 16:46:58 Breakthrough therapy Gilead Sciences Healthcare-associated infections Carbamates Cyclopropanes Ledipasvir/sofosbuvir Sofosbuvir Ombitasvir/paritaprevir/ritonavir Hepatitis C Daclatasvir Ribavirin Hepatitis		State of Illinois Illinois Department of Public Health Ryan White Part B ADAP Medication Assistance Program (MAP) Application for Pre Approval of Hepatitis C Medication Assistance The following medications are n o w avai Add to Reading List Source URL: hivcareconnect.com Download Document from Source Website File Size: 220,69 KB Share Document on Facebook

	State of Illinois Illinois Department of Public Health Ryan White Part B ADAP Medication Assistance Program (MAP) Application for Pre Approval of Hepatitis C Medication Assistance The following medications are n o w avai DocID: 1p7Zv - View Document
	NLT-gruppens yttrande till landstingen gällande nya läkemedel vid kronisk hepatit C: simeprevir (Olysio) sofosbuvir (Sovaldi) och daclatasvir (Daklinza) samt kommentar kring ledipasvir/sofosbuvir (Harvoni) DocID: 1d8mi - View Document
	ANRS HC 32 QUATTRO Etude pilote évaluant l’efficacité et la tolérance d’une QUADRITHERAPIE associant Asunaprevir, Daclatasvir, Ribavirine et Peginterféron alpha-2a chez les patients infectés par le VHC de génot DocID: M0xW - View Document
	New drug could eliminate hepatitis C in 15 years The Pharmaceutical Journal, 10 SEP 2014, By Janna Lawrence Daclatasvir is estimated to cure chronic hepatitis C infection in up to 99% of cases when used in combination wi DocID: JmTC - View Document
	ALLY Trial Demonstrates High Cure Rates for Investigational Daclatasvir and Sofosbuvir Combination among Genotype 3 Hepatitis C Patients Daclatasvir+sofosbuvir regimen achieves SVR12 in 90% of treatment-naïve and 86% of DocID: JfPt - View Document